BlackBarn Capital Partners LP grew its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 65.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 663,397 shares of the company's stock after purchasing an additional 263,397 shares during the period. Privia Health Group makes up 0.7% of BlackBarn Capital Partners LP's portfolio, making the stock its 10th biggest position. BlackBarn Capital Partners LP owned about 0.55% of Privia Health Group worth $12,969,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of the business. Riverbridge Partners LLC raised its position in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after buying an additional 958,418 shares during the period. Geode Capital Management LLC increased its holdings in shares of Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after purchasing an additional 23,178 shares during the period. Loomis Sayles & Co. L P lifted its position in shares of Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after purchasing an additional 503,002 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Privia Health Group by 10.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock worth $27,687,000 after purchasing an additional 138,747 shares during the period. Finally, Franklin Resources Inc. grew its position in Privia Health Group by 0.8% during the fourth quarter. Franklin Resources Inc. now owns 1,311,166 shares of the company's stock valued at $25,633,000 after purchasing an additional 10,926 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.
Privia Health Group Stock Performance
Shares of Privia Health Group stock traded down $0.29 on Friday, reaching $23.17. The stock had a trading volume of 383,161 shares, compared to its average volume of 775,827. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The business's 50-day moving average price is $23.64 and its two-hundred day moving average price is $21.90. The stock has a market cap of $2.81 billion, a P/E ratio of 231.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88.
Insiders Place Their Bets
In related news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This represents a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 10.70% of the company's stock.
Analysts Set New Price Targets
A number of research firms have issued reports on PRVA. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research report on Friday, February 28th. Needham & Company LLC reissued a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. Piper Sandler boosted their target price on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. Canaccord Genuity Group raised their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Finally, Robert W. Baird boosted their price target on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. One analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $27.14.
Read Our Latest Report on PRVA
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Articles
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
